We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Feasibility and outcomes with subclavian vein access for crescent jugular dual lumen catheter for venovenous extracorporeal membrane oxygenation in COVID-19 related acute respiratory distress syndrome.
- Authors
Memon, Sehrish; Drosou, Maria Eleni; Caroline, Mara; Casanova, Elena; Gnall, Eric M
- Abstract
Introduction: Femoral-femoral Veno-Venous ExtraCorporeal Life Support (V-V ECLS) has been associated with higher infections rates, vascular site bleeding complications, and restricted patient mobility. Jugular or bicaval dual lumen V-V ECLS conceptually overcomes some of these adverse factors, but experience has shown that jugular vein cannulation still limits mobility and has increased bleeding complications. Technique and outcomes of subclavian vein single-cannulation with Crescent jugular dual-lumen V-V ECLS is described. Method: five patients with COVID-19 related acute respiratory distress syndrome (ARDS) underwent right subclavian vein V-V ECLS placement with the Crescent 32 French jugular dual-lumen V-V ECLS catheter. A standardized percutaneous technique was developed that allowed efficient insertion without need for any specialized imaging (i.e. transesophageal echocardiogram) and outcomes assessed. Results: Mean age of the five patients was 41.2 years, all obese with an average basal mass index of 45.2 kg/m2 and mean days to decannulation of 24.2 days. Outcomes discovered included; improved patient mobility allowing physical rehabilitation, no vascular access site related complications requiring surgery or endovascular intervention, and none had evidence of superior vena cava syndrome. One patient had subclavian/axillary vein thrombosis with resolution after 3 months of direct-acting oral anticoagulants, and one patient had blood cultures positive at day 37, nearing decannulation. Conclusion: Subclavian vein access for crescent jugular dual lumen V-V ECLS catheter appears to be safe and feasible with added benefits of decreased bleeding and increased mobility over jugular or femoral-femoral access site for long term V-V ECLS support in COVID-19 related ARDS patients.
- Subjects
SUBCLAVIAN veins; COVID-19; BLOOD vessels; ULTRASONIC imaging; CENTRAL venous catheterization; EXTRACORPOREAL membrane oxygenation; RETROSPECTIVE studies; ADULT respiratory distress syndrome; UNITED States. Food &; Drug Administration; DESCRIPTIVE statistics; BODY mass index; DATA analysis software; MEDICAL equipment; DISEASE risk factors
- Publication
Perfusion, 2024, Vol 39, Issue 2, p304
- ISSN
0267-6591
- Publication type
Article
- DOI
10.1177/02676591221137760